Table 3.
Means and (Standard Deviations) for Zinc Pharmacokinetic Study
| Time (hours) | Plasma_Zn (μg/mL) | RBC_Zn (μg/g Hb) | Urine_Zn (μg/mL) |
|---|---|---|---|
| ADHD patients (n = 5) | |||
| 0 | 0.78 (0.09) | 12.63 (7.2) | |
| 1 | 0.94 (0.17) | 14.05 (9.51) | 0.74 (0.32) |
| 2 | 0.83 (0.15) | 10.19 (7.1) | 0.52 (0.26) |
| 4 | 0.76 (0.13) | 9.43 (8.51) | 0.23 (0.1) |
| 5 | 0.72 (0.21) | 10.75 (7.68) | 0.22 (0.1) |
| 7 | 0.67 (0.14) | 10.28 (8.61) | 0.25 (0.22) |
| 9 | 0.64 (0.16) | 10.1 (7.87) | 0.15 (0.09) |
| Normal control subjects (n = 2) | |||
| 0 | 0.79 (0.01) | 5.92 (2.29) | |
| 1 | 1.03 (0.21) | 6.75 (1.25) | 0.79 (0.09) |
| 2 | 0.9 (0.22) | 3.98 (5.57) | 0.77 (0.13) |
| 4 | 0.8 (0.11) | 1.82 (2.51) | 0.22 (0.08) |
| 5 | 0.63 (0.26) | 5.15 (3.65) | 0.17 (0.05) |
| 7 | 0.7 (0.03) | 2.81 (3.95) | 0.15 (0.04) |
| 9 | 0.63 (0.02) | 2.86 (0.7) | 0.11 (0.01) |
ADHD = attention-deficit/hyperactivity disorder; Zn = zinc.